Celgene Corp. (CELG) Stock Rating Reaffirmed by RBC Capital Markets

Celgene Corp. (CELG) Stock Rating Reaffirmed by RBC Capital Markets


's stock had its "outperform" rating restated by investment analysts at RBC Capital Markets in a research report issued to clients and investors on Sunday. Other analysts have also issued reports about the company.



from Biotech News